ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2109355
CHEMBL2109355
Compound Name DUSIGITUMAB
ChEMBL Synonyms MEDI-573 | DUSIGITUMAB
Max Phase 2
Trade Names

Sources

  • Clinical Candidates
  • USP Dictionary of USAN and International Drug Names

Molecule Features

CHEMBL2109355 compound icon
Drug Type:Antibody Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:Unclassified Parenteral:Unclassified Topical:Unclassified Black Box:Unclassified Availability Type:Unclassified

Mechanism of Action

Mechanism of Action ChEMBL Target References
Insulin-like growth factor I inhibitor Insulin-like growth factor I PubMed
Insulin-like growth factor II inhibitor Insulin-like growth factor II PubMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
NeoplasmsD009369EFO:0000311cancer1ClinicalTrials
Carcinoma, HepatocellularD006528EFO:0000182hepatocellular carcinoma1ClinicalTrials
Breast NeoplasmsD001943EFO:0000305breast carcinoma2ClinicalTrials

Clinical Data

ClinicalTrials.gov DUSIGITUMAB
The Cochrane Collaboration DUSIGITUMAB

Compound Cross References

ChemSpider ChemSpider Identifier not yet assigned
spacer
spacer